Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT03415997 Completed - Clinical trials for Contrast Media Dosing

Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight

Start date: February 21, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight. Participants will be randomized into 2 groups based on contrast dosing technique, and solid organ enhancement at uniphasic abdominal CT will be measured.

NCT ID: NCT03411902 Completed - Weight Loss Clinical Trials

Weight Loss With Risedronate for Bone Health

WERISE
Start date: June 15, 2018
Phase: Phase 4
Study type: Interventional

This is a pilot project to determine the feasibility of recruiting, enrolling, treating, and following 24 older sleeve gastrectomy patients into a randomized controlled trial (RCT) examining the efficacy of bisphosphonate use versus placebo in the prevention of surgical weight loss associated loss of bone mass and quality.

NCT ID: NCT03405181 Completed - Infant Development Clinical Trials

Effects of the Additional Weight on the Reaching Behavior of Pre Term Infants With Low Birth Weight

Start date: January 12, 2018
Phase: N/A
Study type: Interventional

The effects of additional weight on early motor skills of infants have been increasingly studied. During the reaching behavior, the additional weight has been shown benefits in certain kinematic variables in full term and preterm infants. There is a growing interest in the study of populations at risk for motor development, especially considering interventions based on functional activities with the purpose of improving the neuromotor control, functional capacity and muscle strength. The aim of the present study is to investigate the effect of a functional training with additional weight in the reaching behavior of preterm infants with low birth weight and to compare the effects with a full term population. A controlled and randomized trial will be carried out with full term infants of adequate birth weight and preterm infants with low birth weight at 6 months of chronological or corrected age. The participants will be recruited by convenience from the charts of a Public Hospital. Participants will be randomly allocated into four groups: 1) adequate weight placebo group (AWPG); 2) adequate weight intervention group (AWIG); 2) low weight placebo group (LWPG) and 4) low weight intervention group (LWIG). . The assessor will be blinded (no knowledge of groups allocation). All infants will undergo a training program of eight sessions (2x/week; 4 weeks). The AWIG and LWIG will receive the training with an additional weight (characterized by a bracelet with a weight of 20% of the mass of the upper limbs)and the AWPG and LWPG will receive the same training, however, without the additional weight (only the bracelets).. All infants will be assessed in three different moments: 1) Pre-intervention: baseline, before the start of the intervention program; 2) Post-intervention: evaluation performed after the end of the program; and 3) Follow-up: evaluation performed seven days after the post-intervention assessment. The following kinematic dependent variables will be calculated: straightness index, mean velocity and motion units and electromyographic variables: pattern of activation and recruitment of muscle fibers - Biceps brachialis, Triceps brachialis, Deltoid and Pectoralis Major muscles; co-activation between biceps and triceps. The Qualisys Track Manager (QTM) and a wireless surface electromyography with 8-channels will be used. If normality assumptions are met, a mixed 2X2 ANOVA with repeated measures will be applied, in order to verify differences between the intervention programs, considering the dependent variables. Otherwise, non-parametric procedures of the same nature will be adopted. The significance will be set at 5% (P<0.05).

NCT ID: NCT03403530 Completed - Neonatal SEPSIS Clinical Trials

Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

IgMNS
Start date: January 30, 2018
Phase: Phase 4
Study type: Interventional

Study comprises of giving IVIG to half of the septic VLBW preterm neonates along with ongoing antibiotics and placebo to the other half. The immunoglobulin will be given for 3 days and neonates will be monitored for the results. The data will be analysed on the basis of blood culture results and outcome of the patients.

NCT ID: NCT03397940 Completed - Physical Activity Clinical Trials

Role of Structured Days on Weight Gain

Start date: March 1, 2018
Phase:
Study type: Observational

Summer vacation is a 3-month window of vulnerability for children from low-income households when health behaviors and academic learning decay. The goal of this project is to collect information on where low-income children go during summer, what they do when they get there, and how their behaviors (physical activity, sedentary, sleep, and diet) differ between the summer (unstructured days) and school year (structured days). This study is 1) significant because it will provide evidence on potential points of intervention that can reduce or reverse the excessive unhealthy weight gains that occur during summer and 2) innovative because it will be the first to identify changes in activity, sedentary, sleep, and dietary behaviors during prolonged and shorter periodic breaks from school and link these behaviors to changes in zBMI over time.

NCT ID: NCT03396029 Completed - Physical Activity Clinical Trials

Tailored Written Lifestyle Feedback in Colorectal Cancer Screening

Start date: November 1, 2014
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to investigate the effect of an individually tailored lifestyle feedback letter and a leaflet on lifestyle in the context of sigmoidoscopy screening.

NCT ID: NCT03395262 Completed - Weight Loss Clinical Trials

An Examination of a Weight Loss Formula on Health

NB14
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.

NCT ID: NCT03389737 Completed - Body Weight Changes Clinical Trials

The Effects of the Novel "Step Up Your Game" Program on Men's Lacrosse

Start date: March 7, 2017
Phase: N/A
Study type: Interventional

For the purpose of this pilot study, the investigators hypothesize that the use of the Step Up Your Game protocol will result in statistically significant improvements in health and athletic performance. The key to this is the coordination of resources from a supervising physician, physical therapist, trainer, dietitian, coach, competitor, role model, psychologist, and spiritual leader. Notably, Step Up Your Game provides resources which would allow patients to find or be their own physical therapist, trainer, dietitian, coach, competitor, role model, psychologist, and spiritual leader. The role of the supervising physician, however, is meant for a qualified professional, who follows the osteopathic approach to medicine, in which the body is treated as an integrated whole, while also working to prevent and treat injuries. Though not limited solely to osteopathic physicians, it is critical to take into account every health aim and injury in the context of the athlete and how these affect all aspects of participants lives.

NCT ID: NCT03384979 Completed - Clinical trials for Contrast Agent With Lean Body Weight

Optimization of Contrast Agent Dose in CT With Lean Body Weight

CA_LBW
Start date: December 18, 2017
Phase: Phase 4
Study type: Interventional

This study evaluates the different enhancement using a contrast agent dose in computed tomography based on total body weight or based on lean body weight. Half of participants will receive contrast agent dose based on their total body weight, while the other half will receive a dose based on their lean body weight. Our hypothesis is that if contrast agent is administered not basing on total body weight but on lean body weight it is possible to obtain equal or better quality of enhanced images, a reduction of the variability of contrast enhancement, and also a dose reduction in some patients (overweight ones).

NCT ID: NCT03383185 Completed - Metabolic Syndrome Clinical Trials

Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives

Start date: January 1, 2010
Phase: N/A
Study type: Observational

Evaluation of metabolic profile of users of hormonal and non-hormonal contraceptives during five years follow-up